Seres Therapeutics Reports Second Quarter 2015 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. USO
2. PENG
3. MTZ
4. FCEL
5. TMUS
6. SPY
7. FLUT
8. FISV
9. AAPL
10. RMD

Go back to Seres Therapeutics Reports Second Quarter 2015 Financial Results and Provides Business Update

Seres Therapeutics (MCRB) Posts Q2 Loss of $1.45/Share

August 6, 2015 7:38 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($1.45), $1.15 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More